Cochlear (Germany) Analysis
| OC5 Stock | EUR 118.92 1.08 0.90% |
200 Day MA 159.7327 | 50 Day MA 151.1184 | Beta 0.509 |
Cochlear Limited has over 874.7 Million in debt which may indicate that it relies heavily on debt financing. The Cochlear's current Short and Long Term Debt is estimated to increase to about 97.4 M, while Long Term Debt is projected to decrease to roughly 38.5 M. Cochlear's financial risk is the risk to Cochlear stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Cochlear's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Cochlear's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Cochlear Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Cochlear's stakeholders.
For many companies, including Cochlear, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Cochlear Limited, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Cochlear's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 7.0071 | Enterprise Value Ebitda 23.1531 | Price Sales 3.3257 | Shares Float 65.2 M | Dividend Share 4.3 |
Cochlear Limited is overvalued with Real Value of 101.08 and Hype Value of 119.72. The main objective of Cochlear stock analysis is to determine its intrinsic value, which is an estimate of what Cochlear Limited is worth, separate from its market price. There are two main types of Cochlear's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Cochlear's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Cochlear's stock to identify patterns and trends that may indicate its future price movements.
The Cochlear stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Cochlear's ongoing operational relationships across important fundamental and technical indicators.
Cochlear |
Cochlear Stock Analysis Notes
About 56.0% of the company shares are owned by institutional investors. The company last dividend was issued on the 19th of March 2026. Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cochlear Limited was incorporated in 1983 and is headquartered in Sydney, Australia. COCHLEAR LTD operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3500 people. To find out more about Cochlear Limited contact MBA BE at 61 2 9428 6555 or learn more at https://www.cochlear.com.Cochlear Limited Investment Alerts
| Cochlear Limited generated a negative expected return over the last 90 days | |
| About 56.0% of the company shares are owned by institutional investors |
Cochlear Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.78 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cochlear's market, we take the total number of its shares issued and multiply it by Cochlear's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Cochlear Profitablity
Cochlear's profitability indicators refer to fundamental financial ratios that showcase Cochlear's ability to generate income relative to its revenue or operating costs. If, let's say, Cochlear is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Cochlear's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Cochlear's profitability requires more research than a typical breakdown of Cochlear's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.22 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.22. Management Efficiency
Cochlear Limited has return on total asset (ROA) of 0.1128 % which means that it generated a profit of $0.1128 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1815 %, meaning that it generated $0.1815 on every $100 dollars invested by stockholders. Cochlear's management efficiency ratios could be used to measure how well Cochlear manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Cochlear's Non Currrent Assets Other are most likely to increase significantly in the upcoming years. The Cochlear's current Other Current Assets is estimated to increase to about 6.1 M, while Total Assets are projected to decrease to roughly 2.2 B.Leadership effectiveness at Cochlear Limited is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 18th of February 2026, Cochlear shows the risk adjusted performance of (0.13), and Mean Deviation of 1.26. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Cochlear, as well as the relationship between them. Please confirm Cochlear Limited variance, treynor ratio, and the relationship between the standard deviation and information ratio to decide if Cochlear Limited is priced correctly, providing market reflects its regular price of 118.92 per share.Cochlear Limited Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Cochlear middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Cochlear Limited. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Cochlear Outstanding Bonds
Cochlear issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cochlear Limited uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cochlear bonds can be classified according to their maturity, which is the date when Cochlear Limited has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Cochlear Predictive Daily Indicators
Cochlear intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cochlear stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 118.92 | |||
| Day Typical Price | 118.92 | |||
| Price Action Indicator | (0.54) | |||
| Period Momentum Indicator | (1.08) |
Cochlear Forecast Models
Cochlear's time-series forecasting models are one of many Cochlear's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cochlear's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Cochlear Limited Debt to Cash Allocation
Many companies such as Cochlear, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Cochlear Limited has accumulated 874.7 M in total debt with debt to equity ratio (D/E) of 25.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Cochlear Limited has a current ratio of 1.81, which is within standard range for the sector. Debt can assist Cochlear until it has trouble settling it off, either with new capital or with free cash flow. So, Cochlear's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cochlear Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cochlear to invest in growth at high rates of return. When we think about Cochlear's use of debt, we should always consider it together with cash and equity.Cochlear Total Assets Over Time
Cochlear Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Cochlear's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Cochlear, which in turn will lower the firm's financial flexibility.Cochlear Corporate Bonds Issued
Most Cochlear bonds can be classified according to their maturity, which is the date when Cochlear Limited has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Cochlear Long Term Debt
Long Term Debt |
|
About Cochlear Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Cochlear prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cochlear shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cochlear. By using and applying Cochlear Stock analysis, traders can create a robust methodology for identifying Cochlear entry and exit points for their positions.
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cochlear Limited was incorporated in 1983 and is headquartered in Sydney, Australia. COCHLEAR LTD operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3500 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Cochlear to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Complementary Tools for Cochlear Stock analysis
When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |